这是一篇来自已证抗体库的有关人类 CEACAM5的综述,是根据11篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CEACAM5 抗体。
CEACAM5 同义词: CD66e; CEA; carcinoembryonic antigen-related cell adhesion molecule 5; meconium antigen 100

赛默飞世尔
小鼠 单克隆(1105)
  • 流式细胞仪; 人类; 图 4
  • 免疫细胞化学; 人类; 图 3
赛默飞世尔 CEACAM5抗体(Thermo Fisher, MIC0101)被用于被用于流式细胞仪在人类样品上 (图 4) 和 被用于免疫细胞化学在人类样品上 (图 3). PLoS ONE (2016) ncbi
小鼠 单克隆(H.426.3)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 3
赛默飞世尔 CEACAM5抗体(Thermo Fisher, MA5-15070)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:50 (图 3). Oncol Lett (2016) ncbi
美天旎
小鼠 单克隆(TET2)
  • 流式细胞仪; 猕猴; 图 1a
美天旎 CEACAM5抗体(Miltenyi Biotec, TET2)被用于被用于流式细胞仪在猕猴样品上 (图 1a). J Immunol (2017) ncbi
圣克鲁斯生物技术
小鼠 单克隆(D-3)
  • 免疫印迹; 人类; 图 S1
圣克鲁斯生物技术 CEACAM5抗体(Santa-Cruz, sc-55547)被用于被用于免疫印迹在人类样品上 (图 S1). PLoS ONE (2015) ncbi
小鼠 单克隆(COL-1)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术 CEACAM5抗体(Santa Cruz Biotechnology, Col1)被用于被用于免疫细胞化学在人类样品上. J Immunol (2014) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(C365D3(NCRC23))
  • 其他; 人类; 200 ug/ml; 图 1
伯乐(Bio-Rad)公司 CEACAM5抗体(AbDSerotec, MCA1744)被用于被用于其他在人类样品上浓度为200 ug/ml (图 1). J Extracell Vesicles (2016) ncbi
安迪生物R&D
小鼠 单克隆(487609)
  • 其他; 人类; 图 2
安迪生物R&D CEACAM5抗体(R&D Systems, MAB41281)被用于被用于其他在人类样品上 (图 2). J Extracell Vesicles (2015) ncbi
赛信通(上海)生物试剂有限公司
小鼠 单克隆(CB30)
  • 免疫组化-石蜡切片; 小鼠; 图 4
赛信通(上海)生物试剂有限公司 CEACAM5抗体(Cell Signaling, CB30)被用于被用于免疫组化-石蜡切片在小鼠样品上 (图 4). Oncoimmunology (2016) ncbi
小鼠 单克隆(CB30)
  • 免疫印迹; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 CEACAM5抗体(Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Cardiovasc Diabetol (2015) ncbi
小鼠 单克隆(CB30)
  • 免疫印迹; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 CEACAM5抗体(Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样品上浓度为1:500. BMC Endocr Disord (2015) ncbi
小鼠 单克隆(CB30)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 CEACAM5抗体(Cell Signaling, 2383)被用于被用于免疫印迹在人类样品上. Tumour Biol (2015) ncbi
文章列表
  1. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed 出版商
  2. Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218 pubmed
  3. Knutson S, Raja E, Bomgarden R, Nlend M, Chen A, Kalyanasundaram R, et al. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer. PLoS ONE. 2016;11:e0157762 pubmed 出版商
  4. Yang Y, Fang J, Li D, Wang L, Ji N, Zhang J. Recurrent intracranial neurenteric cyst with malignant transformation: A case report and literature review. Oncol Lett. 2016;11:3395-3402 pubmed
  5. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  6. Peiris D, Ossondo M, Fry S, Loizidou M, Smith Ravin J, Dwek M. Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer. PLoS ONE. 2015;10:e0138345 pubmed 出版商
  7. He J, Quintana M, Sullivan J, L Parry T, J Grevengoed T, Schisler J, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovasc Diabetol. 2015;14:97 pubmed 出版商
  8. Quintana M, He J, Sullivan J, Grevengoed T, Schisler J, Han Y, et al. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet. BMC Endocr Disord. 2015;15:36 pubmed 出版商
  9. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed 出版商
  10. Aqil M, Elseth K, Arjunakani A, Nebres P, Amegashie C, Thanki D, et al. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties. Tumour Biol. 2015;36:1871-9 pubmed 出版商
  11. Volonté A, Di Tomaso T, Spinelli M, Todaro M, Sanvito F, Albarello L, et al. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4. J Immunol. 2014;192:523-32 pubmed 出版商